Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 13
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Biomarker/Laboratory analysis, Treatment
Active
18 and under
NICHD
PPRU 10762
NCT00491946
Last Modified:
10/15/2008
 
First Published:
7/1/2001
2.
Phase III Randomized Study of Standard Induction Chemotherapy Comprising Vincristine, Dactinomycin, Ifosfamide, and Etoposide Followed By Consolidation Chemotherapy Comprising Vincristine, Dactinomycin, and Ifosfamide Versus High-Dose Busulfan and Melphalan Followed By Autologous Peripheral Blood Stem Cell Support With or Without Radiotherapy and/or Surgery in Patients With Tumor of the Ewing's Family
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 50
NCI, Other
EURO-EWING-INTERGROUP-EE99
EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, NCT00020566, AEWS0331
Last Modified:
1/23/2007
 
First Published:
10/1/2002
3.
Phase III Partially Randomized Study of Neoadjuvant Chemotherapy Followed By Surgery and Adjuvant Chemotherapy in Children With Wilms' Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and under
Other
SIOP-WT-2001
SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138
Last Modified:
10/15/2008
 
First Published:
12/23/2003
4.
Phase III Study of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 50
NCI
COG-ARST0331
NCT00075582, ARST0331
Last Modified:
9/29/2008
 
First Published:
7/7/2006
5.
Phase III Study of Adjuvant Vincristine and Dactinomycin With or Without Doxorubicin Hydrochloride and Radiotherapy or Observation Only in Younger Patients Who are Undergoing Nephrectomy for Newly Diagnosed Stage I-III Favorable Histology Wilms' Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 30 at diagnosis
NCI
COG-AREN0532
AREN0532, NCT00352534
Last Modified:
10/15/2008
 
First Published:
7/14/2006
6.
Phase III Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy in Patients With Newly Diagnosed, Intermediate-Risk Rhabdomyosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 50
NCI
COG-ARST0531
NCT00354835, ARST0531
Last Modified:
5/30/2008
 
First Published:
9/15/2006
7.
Phase III Study of Combination Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed Stage III or IV Favorable Histology Wilms' Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 30
NCI
COG-AREN0533
AREN0533, NCT00379340
Last Modified:
11/30/2006
 
First Published:
9/15/2006
8.
Phase III Randomized Study of Ifosfamide, Vincristine, and Dactinomycin With or Without Doxorubicin in Pediatric Patients With Non-Metastatic Rhabdomyosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 21
Other
CCLG-EPSSG-RMS-2005
EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
Last Modified:
12/11/2006
 
First Published:
10/1/2001
9.
Phase II Study of Chemotherapy Followed By Surgical Resection and Adjuvant Radiotherapy With or Without Autologous Stem Cell Rescue in Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Under 18
Other
CCLG-UKWR
EU-20127, NCT00025103
Last Modified:
10/30/2007
 
First Published:
10/21/2005
10.
Phase II Study of Intensive Chemotherapy Comprising Vincristine, Dactinomycin, and Cyclophosphamide Followed By Vincristine and Dactinomycin in Patients With Lower-Risk Embryonal Rhabdomyosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Under 18
Other
JRSG-UHA-PED03-02
NCT00245089
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute